# Primary hyperthyroidism complicated by primary hyperparathyroidism: a case report and literature review

**Authors:** Hongpeng Guo, Jie Lv, He Zhang, You Li, Xinghe Pan, Junjie Zhang, Chenglin Sun

PMC · DOI: 10.3389/fonc.2025.1524367 · Frontiers in Oncology · 2025-03-28

## TL;DR

This case report describes a rare co-occurrence of primary hyperthyroidism and primary hyperparathyroidism, emphasizing the importance of multidisciplinary teamwork in managing such complex cases.

## Contribution

The paper presents a rare clinical case and highlights the need for personalized preoperative strategies and multidisciplinary collaboration in managing dual endocrine disorders.

## Key findings

- A case of concurrent Graves’ disease and primary hyperparathyroidism was successfully managed through personalized preoperative planning.
- Multidisciplinary team collaboration is essential for determining iodine use, thyroid normalization, and surgical approach.
- Effective preoperative assessment reduces risks of postoperative complications like hyperthyroid crisis and parathyroid insufficiency.

## Abstract

The clinical occurrence of primary hyperthyroidism (PH) combined with primary hyperparathyroidism (PHPT) is exceedingly rare. There remains considerable debate regarding the necessity of iodine use prior to surgery for hyperthyroidism and whether thyroid function should be normalized before proceeding with the operation. Furthermore, the decision on whether to perform total parathyroidectomy or subtotal parathyroidectomy due to parathyroid hyperplasia must be based on a comprehensive assessment by a multidisciplinary team (MDT).

Herein, we report a rare case of concurrent PH, caused by Graves’ disease(GD), and PHPT. Through the collaboration of a MDT, we developed a personalized preoperative preparation and surgical plan for the patient, successfully managing the postoperative complications.

Clinicians should maintain a high level of suspicion for PHPT in hyperthyroid patients with hypercalcemia. Additionally, the decision regarding the preoperative use of iodine, the normalization of thyroid function before surgery, and the surgical approach to parathyroid hyperplasia should be determined through effective preoperative assessment, imaging studies, and MDT collaboration. This strategy allows for the formulation of individualized treatment plans, mitigating the risks of postoperative hyperthyroid crises, recurrence of PHPT, and permanent parathyroid insufficiency.

## Linked entities

- **Diseases:** primary hyperthyroidism (MONDO:1060200), primary hyperparathyroidism (MONDO:0010837), Graves’ disease (MONDO:0005364)

## Full-text entities

- **Diseases:** GD (MESH:D005776), parathyroid hyperplasia (MESH:D010279), hypercalcemia (MESH:D006934), PHPT (MESH:D049950), PH (MESH:D006980), parathyroid insufficiency (MESH:D000309), Graves' disease (MESH:D006111)
- **Chemicals:** iodine (MESH:D007455)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11985462/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11985462/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC11985462/full.md

---
Source: https://tomesphere.com/paper/PMC11985462